About Ambulatório de Ginecologia Endócrina
Clinical Trials at Ambulatório de Ginecologia Endócrina
During the past decade, Ambulatório de Ginecologia Endócrina conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Ambulatório de Ginecologia Endócrina
According to Clinical.Site data, the most researched conditions in "Ambulatório de Ginecologia Endócrina" are
"Menopause" (1 trials) and "Postmenopausal Symptoms" (1 trials). Many other conditions were trialed in "Ambulatório de Ginecologia Endócrina" in a lesser frequency.
Clinical Trials Intervention Types at Ambulatório de Ginecologia Endócrina
Most popular intervention types in "Ambulatório de Ginecologia Endócrina" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Isoflavone" (1 trials), "estradiol" (1 trials) and "isoflavone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ambulatório de Ginecologia Endócrina
The vast majority of trials in "Ambulatório de Ginecologia Endócrina" are
2 trials for "Female" genders.
Clinical Trials Status at Ambulatório de Ginecologia Endócrina
Currently, there are NaN active trials in "Ambulatório de Ginecologia Endócrina".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Ambulatório de Ginecologia Endócrina,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ambulatório de Ginecologia Endócrina, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".